To give some examples, high levels of CCNB1 are associated with a poor prognosis in NSCLC [43], and in the early stages of cancer, high levels of CCNB1 protein are also recognized by the immune system, leading to the production of antibodies and T cells [44]. This evidence concerns the gene CCNB1 and cancer.